Vet

No Dog Left Behind: Plan of Action to Address Drug Shortages

Christina K. Lopes

As you are likely aware, global supply chain issues are causing shortages of crucial raw drug ingredients needed to produce targeted therapy medications. These shortages are having a significant impact on the veterinary compounding pharmacy industry, and we know that you, your patients and pet parents are feeling the effects.

We want you to know that the FidoCure® team shares your sense of urgency and we are working hard to ensure that no dog is left without the cancer treatments it needs.

Providing access to life-saving therapies is one of our core values, and we are committed to putting you and your patients first.

Here are just a few of the steps we are taking to mitigate the effects of these supply chain issues:

  • We have partnered with three new veterinary compounding pharmacies and continue to explore additional partnerships to gain access to supply.
  • We are taking on additional costs to ensure that we locate medications for our patients, and we will not pass those additional costs on to our customers.
  • We are actively monitoring ingredient stock levels to anticipate shortages and explore workarounds before they happen.
  • We are facilitating prescription transfers and providing ordering support during any transition.
  • We are working closely with individual clinics to find solutions on a case-by-case basis, wherever possible.

We understand that a cancer diagnosis for a beloved pet can be devastating, and the inability to access the necessary treatments due to supply chain shortages only adds to the feeling of helplessness.

We are fully committed to providing the best possible care for your patients and helping you through this difficult time. Thank you for your dedication to your patients, and please know that we are here to support you in any way we can.

DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy. 

© Copyright 2018-2022 OHC, All rights reserved